RACHEL YOUNGBLOOD: Open Payments
NPI 1033405477 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 23 payments from 21 companies in 2025. Trend: 2023 $3,399 · 2024 $2,503 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 1 | $38 |
| ARRAY BIOPHARMA INC | 2 | $35 |
| PFIZER INC. | 2 | $35 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Celgene Corporation | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $26 |
| Blueprint Medicines Corporation | 1 | $26 |
Products named: ZEPZELCA, LONSURF, KISQALI, NINLARO, REBLOZYL, Orserdu, Trodelvy, AYVAKIT.
Industry payments across GA — which companies pay providers there.
